These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23190794)

  • 21. Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.
    Spoelstra-de Man AM; van Ittersum FJ; Schram MT; Kamp O; van Dijk RA; Ijzerman RG; Twisk JW; Brouwer CB; Stehouwer CD
    J Hum Hypertens; 2006 Aug; 20(8):599-611. PubMed ID: 16673014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effect of carvedilol: a preliminary dose-response study.
    Casadei B; Conway J; Coats AJ; Bird R
    Clin Investig; 1992; 70 Suppl 1():S37-8. PubMed ID: 1350482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
    Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of antihypertensive treatment with Lisinopril: a chronotherapeutic approach.
    Macchiarulo C; Pieri R; Mitolo DC; Pirrelli A
    Eur Rev Med Pharmacol Sci; 1999; 3(6):269-75. PubMed ID: 11261739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
    Dahlöf B
    Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study.
    Duprez DA; Florea ND; Jones K; Cohn JN
    J Am Coll Cardiol; 2007 Aug; 50(9):835-9. PubMed ID: 17719468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.
    Herrera-Arellano A; Miranda-Sánchez J; Avila-Castro P; Herrera-Alvarez S; Jiménez-Ferrer JE; Zamilpa A; Román-Ramos R; Ponce-Monter H; Tortoriello J
    Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, parallel comparative study of the antihypertensive efficacy of once-daily lisinopril vs enalapril with 24-h ambulatory blood pressure monitoring in essential hypertension.
    Coca A; Sobrino J; Módol J; Soler J; Mínguez A; Plana J; De la Sierra A
    J Hum Hypertens; 1996 Dec; 10(12):837-41. PubMed ID: 9140792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
    Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
    J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
    Bañares R; Moitinho E; Matilla A; García-Pagán JC; Lampreave JL; Piera C; Abraldes JG; De Diego A; Albillos A; Bosch J
    Hepatology; 2002 Dec; 36(6):1367-73. PubMed ID: 12447861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double blind comparative study of lisinopril and enalapril in patients with essential hypertension.
    Johnston GD; Banks DC; Davies S; Duffin D; Garnham JC; Nicholls DP; Raj MV; Mansy S; Sloan P; Strouthidis TM
    J Hum Hypertens; 1991 Oct; 5(5):405-10. PubMed ID: 1663163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group.
    Chrysant SG
    Arch Intern Med; 1994 Apr; 154(7):737-43. PubMed ID: 8147677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of pathophysiologic changes with long-term lisinopril treatment in isolated systolic hypertension.
    Heesen WF; Beltman FW; Smit AJ; May JF; de Graeff PA; Muntinga JH; Havinga TK; Schuurman FH; van der Veur E; Meyboom-de Jong B; Lie KI
    J Cardiovasc Pharmacol; 2001 May; 37(5):512-21. PubMed ID: 11336102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt].
    Babkin AP; Gladkikh VV; Pershukov IV; Gulaia GI
    Kardiologiia; 2010; 50(10):35-8. PubMed ID: 21118177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the EVIDENCE study.
    Duprez DA; Florea N; Duval S; Koukol C; Cohn JN
    J Hum Hypertens; 2017 Dec; 32(1):20-25. PubMed ID: 29184167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain imaging findings predict blood pressure response to pharmacological treatment.
    Jennings JR; Muldoon MF; Whyte EM; Scanlon J; Price J; Meltzer CC
    Hypertension; 2008 Dec; 52(6):1113-9. PubMed ID: 18981325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.